REGENXBIO Funding: $110M Raised, Series D (2015)

REGENXBIO funding overview

REGENXBIO is based in Rockville, MD. REGENXBIO has raised $110M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series D announced in May 2015. The round record for REGENXBIO runs through 2015; nothing later has been disclosed. Investors on record include Vivo Capital, Venrock, Brookside Capital, Janus Capital Management LLC, Jennison Associates LLC, Perceptive Advisors, LLC and 8 others. 14 distinct backers are named across the disclosed rounds.

REGENXBIO at a glance

Total raised: $110M
Latest round: Series D
Latest round date: May 2015
Headquarters: Rockville, MD
Notable investors: Vivo Capital, Venrock, Brookside Capital, Janus Capital Management LLC, Jennison Associates LLC, Perceptive Advisors, LLC, QVT Financial LP, Tourbillon Global Ventures

Frequently asked about REGENXBIO funding

How much has REGENXBIO raised?: REGENXBIO has raised $110M in total disclosed funding across the rounds on record.
Who has invested in REGENXBIO?: Vivo Capital, Venrock, Brookside Capital, Janus Capital Management LLC, Jennison Associates LLC, Perceptive Advisors, LLC are named among the investors backing REGENXBIO.
What was the latest REGENXBIO funding round?: The most recent disclosed round is a Series D, announced in May 2015.
Where is REGENXBIO based?: REGENXBIO is based in Rockville, MD.
When did REGENXBIO last raise?: The last disclosed REGENXBIO round closed in May 2015 at Series D.

REGENXBIO totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Rockville below to benchmark round size and investor mix.

REGENXBIO Funding: $110M Raised, Series D (2015)

REGENXBIO funding overview

REGENXBIO at a glance

Frequently asked about REGENXBIO funding

Companies related to REGENXBIO (29)

Browse related funding lists (5)